In-Vitro Diagnostics (IVD) Market by Product (Instruments, Reagents, and Services), by Technology (Immunology, Hematology, Clinical Chemistry, Molecular Diagnostics, Coagulation, Microbiology, and Others), by Application (Infectious Disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, and Others), and by End-Use (Hospital, Laboratory, Home Care, and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029
- TBI59114
- July 24, 2020
- Global
- 132 pages
- SAC Insights
Abstract
The report covers a forecast and an analysis for the in-vitro diagnostics (IVD) market on a global and regional level. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the in-vitro diagnostics (IVD) market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities and threats to the in-vitro (IVD) market on a global level.
To understand the competitive landscape in the market, an analysis of Porter's Five Forces Model for the in-vitro diagnostics (IVD) market has also been included. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the in-vitro diagnostics (IVD) market based on product, technology, application, end-use, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.
Some key players of the global in-vitro diagnostics (IVD) market are Alere, bioMerieux SA, Becton, Dickinson, and Company, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Qiagen, Hologic, Inc. (Gen-Probe), Abbott, Danaher, Sysmex Corporation, and Cepheid.
This report segments the global in-vitro diagnostics (IVD) market into:
Global In-Vitro Diagnostics (IVD) Market: By Product
Instruments
Reagents
Services
Global In-Vitro Diagnostics (IVD) Market: By Technology
Immunology
Hematology
Clinical Chemistry
Molecular Diagnostics
Coagulation
Microbiology
Others
Global In-Vitro Diagnostics (IVD) Market: By Application
Infectious Disease
Diabetes
Oncology
Cardiology
Nephrology
Autoimmune Diseases
Drug Testing
Others
Global In-Vitro Diagnostics (IVD) Market: By End-Use
Hospital
Laboratory
Home Care
Others
Global In-Vitro Diagnostics (IVD) Market: By Region
North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa
Table of Contents
Request Table Of Content
Click To Request Sample
Chapter 1. Introduction
1.1. Report Description and Scope
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
Chapter 2. Executive Summary
2.1. Global In-Vitro Diagnostics (IVD) Market, 2015-2025 (USD Million)
2.2. Global In-Vitro Diagnostics (IVD) Market: Snapshot
| read more...
Related Reports
